Klinische Pädiatrie

Issue 03 · May 2014

eFirst
Issue
XXVII. Jahrestagung der Kind-Philipp-Stiftung für Leukämieforschung
Wilsede, Lüneburger Heide, 11. – 14. Juni 2014

Wissenschaftliche Leitung: Prof. Dr. Martin Horstmann; Prof. Dr. Martin Stanulla; Prof. Dr. Rolf Marschalek

Abstracts (HTML) List of Authors
- Session: Klinik und Molekularbiologie von Leukämien
A1
Gramlich, A; Kowarz, E; Marschalek, R:
Investigating the interplay between the Iroquois homeoprotein family and MLL or derivatives thereof
FREE ACCESS
- HTML
A15
Schirmer, M; Queudeville, M; Trentin, L; Eckhoff, SM; Meyer, LH; Debatin, KM:
Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical all xenograft model
FREE ACCESS
- HTML
A2
Meyer, C; Marschalek, R:
The MLL recombinome
FREE ACCESS
- HTML
A3
Fedders, H; Zimmermann, M; Cario, G; Möricke, A; Schrappe, M; Stanulla, M:
Prognostic impact of FLT3 gene expression and mutational status in pediatric MLL-rearranged ALL
FREE ACCESS
- HTML
A4
Fluhr, S; Meier, A; Krombholz, CF; Niemeyer, CM; Flotho, C:
Epigenetic changes accompany altered hemoglobin regulation in juvenile myelomonocytic leukemia
FREE ACCESS
- HTML
A5
Schmäh, J; Müller, S; Grunz, F; Harms, H; Rotter, B; Koch, I; Kahl, G; Winter, P; Schrappe, M; Stanulla, M; Cario, G:
Two subgroups of CRLF2-overexpressing pediatric acute lymphoblastic leukemias differ in outcome and gene expression
FREE ACCESS
- HTML
A6
Krombholz, CF; Aumann, K; Bertele, D; Meier, A; Niemeyer, CM; Flotho, C; Erlacher, M:
Rag2null/γcnull mice are suitable for long-term in vivo propagation of juvenile myelomonocytic leukemia
FREE ACCESS
- HTML
A7
Torge, A; Zimmermann, M; Möricke, A; Köhler, R; Alten, J; Bartram, CR; Schrappe, M; Stanulla, M:
Prediction of minimal residual disease in pediatric ALL: Comparison and evaluation of different mathematical methods applied to data from the ALL-BFM 2000 trial
FREE ACCESS
- HTML
A8
Alsadeq, A; Strube, S; Krause, S; Carlet, M; Jeremias, I; Vokuhl, C; Loges, S; Aguirre-Ghiso, JA; Cario, G; Stanulla, M; Schrappe, M; Schewe, DM:
Regulating the activity of p38α/β as a potential therapy against childhood acute lymphoblastic leukemia
FREE ACCESS
- HTML
A9
Ponthan, F; Pal, D; Vormoor, J; Heidenreich, O:
Establishment of a genome-wide RNAi screen; Identification of novel genes involved in clonal maintenance of ALL
FREE ACCESS
- HTML
A10
Dagdan, E; Zaliova, M; Zimmermann, M; Dörge, P; Möricke, A; Teigler-Schlegel, A; Koehler, R; Bartram, CR; Alten, J; Schewe, D; Kratz, C; Houlston, RS; Schrappe, M; Cario, G; Stanulla, M:
Concurrent deIetions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 (IKZF1plus) confer a very poor prognosis in pediatric acute lymphoblastic leukemia
FREE ACCESS
- HTML
A11
Dormon, K; Heidenreich, O:
Darwinian Evolution of Acute Lymphoblastic Leukaemia
FREE ACCESS
- HTML
A12
McKenzie, L; Martinez-Soria, N; Bonifer, C; Heidenreich, O:
A role for Dual Specificity Phosphatase 6 (DUSP6) in the propagation and self-renewal of Acute Myeloid Leukaemia (AML)
FREE ACCESS
- HTML
A13
Münch, V; Hasan, N; Schirmer, M; Mirjam Eckhoff, S; Debatin, KM; Meyer, LH:
In vivo response to remission induction poly-chemotherapy in NOD/SCID/huALL reflects patient risk and outcome
FREE ACCESS
- HTML
A14
Martinez-Soria, N; Blair, H; Heidenreich, O:
“In vivo” shRNA screen for the identification of the RUNX1/ETO targets with a relevance in leukaemogenesis
FREE ACCESS
- HTML
A16
Szymansky, A; Groeneveld-Krentz, S; Hof, J; Kirschner-Schwabe, R; Eckert, C:
Improving Diagnostic Methods for Minimal Residual Disease Detection (MRD) in Childhood Acute Lymphoblastic Leukemia (ALL)
FREE ACCESS
- HTML